Nothing Special   »   [go: up one dir, main page]

Chaudhary, 2013 - Google Patents

Effect of L-thyroxine and PTU on oxidative stress induced by carbontetrachloride treated rats

Chaudhary, 2013

View PDF
Document ID
2481293705338803810
Author
Chaudhary K
Publication year
Publication venue
J. Exp. Zool. In-dia

External Links

Snippet

Carbontetrachloride is metabolized by cytochrome P-450 2EI (CYP2E1) to the trichloromethyl radieal (CCI), which is assumed to initiate free radical medinted ipid peroxidation lending to the accumulation of lipidderived oxidation products that cause liver …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl group being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides

Similar Documents

Publication Publication Date Title
Prakasam et al. Plasma and RBCs antioxidant status in occupational male pesticide sprayers
Yousef et al. Dietary zinc deficiency induced-changes in the activity of enzymes and the levels of free radicals, lipids and protein electrophoretic behavior in growing rats
Corkey Banting lecture 2011: hyperinsulinemia: cause or consequence?
Zaidi et al. Effects of antioxidant vitamins on glutathione depletion and lipid peroxidation induced by restraint stress in the rat liver
Jung et al. Antihyperglycemic and antioxidant properties of caffeic acid in db/db mice
Balkan et al. Improving effect of dietary taurine supplementation on the oxidative stress and lipid levels in the plasma, liver and aorta of rabbits fed on a high-cholesterol diet
Vaglio et al. Changes in liver enzyme activity in the TeleostSparus auratain response to cadmium intoxication
Mirabelli et al. Menadione-induced bleb formation in hepatocytes is associated with the oxidation of thiol groups in actin
Grattagliano et al. Starvation impairs antioxidant defense in fatty livers of rats fed a choline-deficient diet
Bhuvaneswari et al. Astaxanthin restricts weight gain, promotes insulin sensitivity and curtails fatty liver disease in mice fed a obesity-promoting diet
Babu et al. Renal lesions in streptozotocin-induced diabetic rats maintained on onion and capsaicin containing diets
Yavuz et al. Protective effect of melatonin on β-cell damage in streptozotocin-induced diabetes in rats
Maheswari et al. Antihepatotoxic effect of grape seed oil in rat
ISHII et al. Induction of outer and inner ring monodeiodinases in human thyroid gland by thyrotropin
Balkan et al. The effect of taurine or betaine pretreatment on hepatotoxicity and prooxidant status induced by lipopolysaccharide treatment in the liver of rats
Kim et al. Effects of cysteine on amino acid concentrations and transsulfuration enzyme activities in rat liver with protein–calorie malnutrition
Allagui et al. Protective effects of vitamins (C and E) and melatonin co-administration on hematological and hepatic functions and oxidative stress in alloxan-induced diabetic rats
Hwang et al. Effect of taurine on toxicity of oxidized fish oil in rats
Bondy et al. Aluminum but not iron treatment induces pro-oxidant events in the rat brain
Anuradha Aminoacid support in the prevention of diabetes and diabetic complications
Deshpande et al. Effect of antioxidants (vitamin C, E and turmeric extract) on methimazole induced hypothyroidism in rats
Armeni et al. Studies on the life prolonging effect of food restriction: glutathione levels and glyoxalase enzymes in rat liver
Vidyashankar et al. Liv. 52 protects HepG2 cells from oxidative damage induced by tert-butyl hydroperoxide
Ume Salma et al. Ameliorative effect of flaxseed (Linum usitatissimum) and its protein on ethanol‐induced hepatotoxicity in Wistar rats
Ha et al. Antioxidant mechanism of black garlic extract involving nuclear factor erythroid 2-like factor 2 pathway